Figure 5.
Overall survival (A) and disease free survival (B) according to oxaliplatin based adjuvant chemotherapy vs. no oxaliplatin based chemotherapy in low PARP-1 expression gastric cancer group.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.